Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edenfield

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Clinical Biochemistry|September 15, 2007
Quantification of urinary 8-iso-PGF2alpha using liquid chromatography-tandem mass spectrometry and association with elevated troponin levelsAmy K Saenger, Thomas J Laha, Michael J Edenfield, et al.
Research Square|January 7, 2025
Impact of Frequent ARID1A Mutations on Protein Stability: Insights into Cancer PathogenesisRajen K Goutam, Gangtong Huang, Exequiel Medina, et al.
Scientific Reports|January 24, 2025
Impact of frequent ARID1A mutations on protein stability provides insights into cancer pathogenesisRajen K Goutam, Gangtong Huang, Exequiel Medina, et al.
Chest|October 26, 1999
Mechanical ventilation in hematopoietic stem cell transplantation: can We effectively predict outcomes?A F Shorr, L K Moores, W J Edenfield, et al.
Investigative Ophthalmology & Visual Science|December 1, 1991
Pharmacokinetic study of recombinant human epidermal growth factor in the anterior eyeK Y Chan, T D Lindquist, M J Edenfield, et al.
Journal of Clinical Pharmacology|June 1, 2017
Safety and Pharmacokinetics of Bendamustine Rapid-Infusion FormulationEric M Cheung, William J Edenfield, Bassam Mattar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?C K Murray, E Estey, E Paietta, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2022
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic MalignanciesAmer M Zeidan, Rachel J Cook, Rodolfo Bordoni, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 6, 2007
The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's diseasePaola Costa-Mallen, Harvey Checkoway, Aram Zabeti, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2023
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumorsMats Någård, Mei-Lin Ah-See, James Strauss, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Clinical Biochemistry|September 15, 2007
Quantification of urinary 8-iso-PGF2alpha using liquid chromatography-tandem mass spectrometry and association with elevated troponin levelsAmy K Saenger, Thomas J Laha, Michael J Edenfield, et al.
Research Square|January 7, 2025
Impact of Frequent ARID1A Mutations on Protein Stability: Insights into Cancer PathogenesisRajen K Goutam, Gangtong Huang, Exequiel Medina, et al.
Scientific Reports|January 24, 2025
Impact of frequent ARID1A mutations on protein stability provides insights into cancer pathogenesisRajen K Goutam, Gangtong Huang, Exequiel Medina, et al.
Chest|October 26, 1999
Mechanical ventilation in hematopoietic stem cell transplantation: can We effectively predict outcomes?A F Shorr, L K Moores, W J Edenfield, et al.
Investigative Ophthalmology & Visual Science|December 1, 1991
Pharmacokinetic study of recombinant human epidermal growth factor in the anterior eyeK Y Chan, T D Lindquist, M J Edenfield, et al.
Journal of Clinical Pharmacology|June 1, 2017
Safety and Pharmacokinetics of Bendamustine Rapid-Infusion FormulationEric M Cheung, William J Edenfield, Bassam Mattar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?C K Murray, E Estey, E Paietta, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 9, 2022
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic MalignanciesAmer M Zeidan, Rachel J Cook, Rodolfo Bordoni, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 6, 2007
The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's diseasePaola Costa-Mallen, Harvey Checkoway, Aram Zabeti, et al.
Cancer Chemotherapy and Pharmacology|July 2, 2023
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumorsMats Någård, Mei-Lin Ah-See, James Strauss, et al.
Pageof 4